[1] Marinus J, Zhu K, Marras C, et al.Risk factors for non-motor symptoms in Parkinson's disease[J]. Lancet Neurol,2018,17(6):559-568.
[2] Suzuki K, Miyamoto M, Miyamoto T, et al.Parkinson's disease and sleep/wake disturbances[J]. Curr Neurol Neurosci Rep,2015,15(3):8.
[3] Mehta SH, Morgan JC, Sethi KD.Sleep disorders asso-ciated with Parkinson's disease: role of dopamine, epidemiology, and clinical scales of assessment[J]. CNS Spectr,2008,13(Suppl 4):6-11.
[4] Neikrug AB, Maglione JE, Liu L, et al.Effects of sleep disorders on the non-motor symptoms of Parkinson di-sease[J]. J Clin Sleep Med,2013,9(11):1119-1129.
[5] Xiang W, Sun Y Q, Teoh H C.Comparison of nocturnal symptoms in advanced Parkinson's disease patients with sleep disturbances: pramipexole sustained release versus immediate release formulations[J]. Drug Des Devel Ther,2018,12:2017-2024.
[6] Selvaraj VK, Keshavamurthy B. Sleep Dysfunction in Parkinson's Disease[J]. J Clin Diagn Res,2016,10(2):OC09-12.
[7] Maiga B, Diop MS, Sangare M, et al.Sleep quality assessment in 35 Parkinson's disease patients in the Fann Teaching Hospital, Dakar, Senegal[J]. Rev Neurol (Paris),2016,172(3):242-247.
[8] Bostantjopoulou S, Katsarou Z, Karakasis C, et al.Evalua-tion of non-motor symptoms in Parkinson's Disease: An underestimated necessity[J]. Hippokratia,2013,17(3):214-219.
[9] Suzuki K, Miyamoto T, Miyamoto M, et al.Evaluation of cutoff scores for the Parkinson's disease sleep scale-2[J]. Acta Neurol Scand,2015,131(6):426-430.
[10] Mollayeva T, Thurairajah P, Burton K, et al.The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis[J]. Sleep Med Rev,2016,25:52-73.
[11] Thompson E.Hamilton Rating Scale for Anxiety (HAM-A)[J]. Occup Med (Lond), 2015, 65(7):601.
[12] Torbey E, Pachana NA, Dissanayaka NN.Depression ra-ting scales in Parkinson's disease: A critical review updating recent literature[J]. J Affect Disord,2015,184:216-224.
[13] Lee DH, Cho CH, Han C, et al.Sleep Irregularity in the Previous Week Influences the First-Night Effect in Polysomnographic Studies[J]. Psychiatry Investig,2016, 13(2):203-209.
[14] Thomas RJ, Mietus JE2, Peng CK, et al. Relationship between delta power and the electrocardiogram-derived cardiopulmonary spectrogram: possible implications for assessing the effectiveness of sleep[J]. Sleep Med,2014, 15(1):125-131.
[15] Frampton J E.Pramipexole extended-release: a review of its use in patients with Parkinson's disease[J]. Drugs,2014,74(18):2175-2190.
[16] Armitage R, Trivedi M, Hoffmann R, et al.Relationship between objective and subjective sleep measures in depressed patients and healthy controls[J]. Depress Anxiety,1997,5(2):97-102.
[17] Feige B, Al-Shajlawi A, Nissen C, et al.Does REM sleep contribute to subjective wake time in primary insomnia? A comparison of polysomnographic and subjective sleep in 100 patients[J]. J Sleep Res,2008,17(2):180-190.
[18] Tamaki M, Nittono H, Hayashi M, Hori T, et al.Examination of the first-night effect during the sleep-onset pe-riod[J]. Sleep,2005,28(2):195-202.
[19] Thomas RJ, Mietus JE, Peng CK, et al.An electrocardiogram-based technique to assess cardiopulmonary coupling during sleep[J]. Sleep,2005,28(9):1151-1161.
[20] Chen L, Liu C, Ye Z, et al.Assessment of sleep quality using cardiopulmonary coupling analysis in patients with Parkinson's disease[J]. Brain Behav,2018,8(5):e00970.
